Rates of Bleeding and Venous Thromboembolism (VTE) Events Reported After 12 Months of Edoxaban Treatment Considered Lo

([1]) Agnelli, G. et al. Edoxaban Treatment of Venous Thromboembolism in Routine Clinical Practice in the Non-Interventional Global ETNA-VTE Program: A Sub-analysis by Age Groups. Poster presented at the International Society on Thrombosis and Haemostasis (ISTH) 2020 Virtual Congress.

(([2])) Schindewolf, M. et al. ETNA-VTE Europe: The Effect of Body Mass Index on 12-Month Outcomes in VTE Patients with Edoxaban. Poster presented at the International Society on Thrombosis and Haemostasis (ISTH) 2020 Virtual Congress.

(([3])) Coppens, M. et al. Association between index venous thromboembolism (VTE) event and 12-months outcomes for patients in routine clinical practice enrolled in the Edoxaban Treatment in routine cliNical prActice for patients with acute VTE in Europe (ETNA-VTE-Europe) registry. Poster presented at the International Society on Thrombosis and Haemostasis (ISTH) 2020 Virtual Congress.

([4]) ISTH Steering Committee for World Thrombosis Day. Thrombosis: A major contributor to global disease burden. J Thromb Haemost. 2014 Oct;12(10):1580-90.

([5]) The Coalition to Prevent VTE. Available at: http://www.coalitiontopreventvte.org/IND.... Last accessed June 2020.

([6]) Zagaria, M. Venous Thrombosis: Pathogenesis and Potential for Embolism. US Pharm. 2009;34:22-24.

([7]) Cohen, A. et al. ETNA-VTE Global: Evaluation of Bleeding Risk Based on VTE-BLEED Score on 12-month Outcomes in a Population Treated with Edoxaban. Poster presented at the International Society on Thrombosis and Haemostasis (ISTH) 2020 Virtual Congress.

([8]) Cohen, A. et al. ETNA VTE Europe: A Contemporary Snapshot of VTE Patients Treated with Edoxaban in Clinical Practice across Eight European Countries. Poster presented at the International Society on Thrombosis and Haemostasis (ISTH) 2020 Virtual Congress.

EDX/20/0641, Date of preparation: July 2020

Media ContactDr. Wolfgang Schiessl
Daiichi Sankyo Europe GmbH
Director Product PR and Communications
Cardiovascular Europe
+49-151-1714-7317

Web site: https://www.daiichi-sankyo.eu/